COVID-KOSHA
Home
Help
(current)
Comment
!
Note: Language translations may be imperfect
A model anti-pandemic portal for scientists & public
;
High priority articles (R1, Most articles most likely to be relevant):
Second priority articles (R2, Moderate portion of articles likely to be relevant):
Other articles (R3, Lesser portion of articles likely to be relevant):
Auto Summaries -
Pathophysiology
Last updated: 2024 Nov 18
Total hit(s): 29444
S.No.
PMID
Ascending order
Descending order
Title
Ascending order
Descending order
Auto Summary
Ascending order
Descending order
Journal Name
Ascending order
Descending order
Publish Date
Ascending order
Descending order
Impact Factor
Ascending order
Descending order
Citations
Ascending order
Descending order
1
39520876
Erratum to 'Seasonality and severity of respiratory syncytial virus during the COVID-19 pandemic: a dynamic cohort study'.
N/A
Int J Infect Dis
2024 Nov 8
3.42
1
2
39514137
Author Correction: Prevalence and risk factors for lung involvement on low-dose chest CT (LDCT) in a paucisymptomatic population of 247 patients affected by COVID-19.
N/A
Insights Imaging
2024 Nov 8
3.55
1
3
39511402
Author Correction: Epidemiology and analysis of SARS-CoV-2 Omicron subvariants BA.1 and 2 in Taiwan.
N/A
Sci Rep
2024 Nov 7
4.12
1
4
39522531
Impact of JN.1 booster vaccination on neutralisation of SARS-CoV-2 variants KP.3.1.1 and XEC.
N/A
Lancet Infect Dis
2024 Nov 7
21.77
1
5
39503179
Immunity Debt Associated With Increased Immunological Reactions of M. pneumoniae Pneumonia in Children After the COVID-19 Pandemic.
N/A
Pediatr Pulmonol
2024 Nov 6
2.64
1
6
39503475
Lung damage in SARS-CoV-2 patients: Correspondence.
N/A
Eur J Clin Invest
2024 Nov 6
2.84
1
7
39495325
Reflections on awake prone positioning in COVID-19: considerations on body inclination, respiratory support, and patient variability.
N/A
Intensive Care Med
2024 Nov 4
8.61
1
8
39496847
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.
N/A
J Thromb Thrombolysis
2024 Nov 4
3.07
1
9
39491729
Covid-19 mRNA vaccine allergy.
N/A
J Allergy Clin Immunol
2024 Nov 2
8.2
1
10
39545819
Correction to: Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination.
N/A
Clin Infect Dis
2024 Nov 15
7.71
1
11
39496449
Significance of Persistent Systemic Support in the Clinical Course of Delayed Post-hypoxic Leukoencephalopathy following Severe Coronavirus Disease 2019.
N/A
Intern Med
2024 Nov 1
0.29
1
12
38979807
Anti-rubella IgG serum levels predict risk for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) breakthrough infections.
N/A
Allergy
2024 Nov
8.7
1
13
39538404
Transcriptomic profiling reveals the dynamics of fibrotic progression-related gene expression into post-coronavirus disease 2019 pulmonary fibrosis.
N/A
Clin Transl Med
2024 Nov
4.08
1
14
39521553
Delta and Omicron SARS-CoV-2 Outcomes in Vaccinated Individuals With Chronic Lung Disease: Comment.
N/A
Chest
2024 Nov
7.22
1
15
39521579
Letter to the Editor: "Improving Risk Analysis for Fatal Thrombosis in COVID-19: A Call for Targeted Anticoagulation" regarding: "Incidence, Predictors, and Outcomes of Venous and Arterial Thrombosis in COVID-19: A Nationwide Inpatient Analysis" by Agrawal et al. Heart Lung Circ. 2024;33(11):1563-73.
N/A
Heart Lung Circ
2024 Nov
1.93
1
16
39382692
Towards improved management of pulmonary herpes simplex virus and cytomegalovirus in COVID-19 ARDS: a future perspective. Author's reply.
N/A
Intensive Care Med
2024 Oct 9
8.61
1
17
39393107
Poor stress resilience as an independent risk factor for severe COVID-19 and respiratory infections.
N/A
J Psychosom Res
2024 Oct 9
4.8
1
18
39365475
Reply to Letter to the Editor: "Ultra-low-dose vs. standard-of-care-dose CT of the chest in patients with post-COVID-19 conditions-a prospective intra-patient multi-reader study".
N/A
Eur Radiol
2024 Oct 4
3.11
1
19
39447388
Corrigendum to "Middle East respiratory syndrome coronavirus-a 10-year (2012-2022) global analysis of human and camel infections, genomic sequences, lineages, and geographical origins" [International Journal of Infectious Diseases (2023), volume 131, 87-94].
N/A
Int J Infect Dis
2024 Oct 23
3.42
1
20
39447273
Letter to the Editor: "Portal hypertension-like pattern in coronavirus disease 2019 acute respiratory distress syndrome".
N/A
J Crit Care
2024 Oct 23
2.83
1
21
39438808
Correction: A pulmonary rehabilitation program is an effective strategy to improve forced vital capacity, muscle strength, and functional exercise capacity similarly in adults and older people with post-severe COVID-19 who required mechanical ventilation.
N/A
BMC Geriatr
2024 Oct 22
4.5
1
22
39428723
Mastocytosis and the trigger for pulmonary fibrosis and thrombosis in patients affected by COVID-19.
N/A
Histopathology
2024 Oct 20
3.46
1
23
39365476
Letter to the Editor: "Ultra-low-dose vs standard-of-care-dose CT of the chest in patients with post-COVID-19 conditions-a prospective intra-patient multi-reader study".
N/A
Eur Radiol
2024 Oct 2
3.11
1
24
39415603
Metabolic dysfunction-associated steatotic liver disease and BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant: correspondence.
N/A
J Gastroenterol Hepatol
2024 Oct 17
3.4
1
25
39401742
Risk of Acute Aortic Events Following COVID-19 and Influenza Respiratory Viral Infections: Comment.
N/A
Ann Vasc Surg
2024 Oct 12
1.18
1